Measurement of health-related quality of life during chemotherapy - the importance of timing.

about

Effects of Behavioral Activation on the Quality of Life and Emotional State of Lung Cancer and Breast Cancer Patients During Chemotherapy Treatment.

P2860

Q47569890-44B280FB-F05D-4DAA-9688-09D4421456D0

P2860

Measurement of health-related quality of life during chemotherapy - the importance of timing.

Item

http://www.wikidata.org/entity/Q50935978

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Measurement of health-related ...... py - the importance of timing.

@en

Measurement of health-related ...... py - the importance of timing.

@nl

type

Item

label

Measurement of health-related ...... py - the importance of timing.

@en

Measurement of health-related ...... py - the importance of timing.

@nl

prefLabel

Measurement of health-related ...... py - the importance of timing.

@en

Measurement of health-related ...... py - the importance of timing.

@nl

P1476

Measurement of health-related ...... py - the importance of timing.

@en

P2093

Are Kristensen

http://www.w3.org/2001/XMLSchema#string

Bjørn H Grønberg

http://www.w3.org/2001/XMLSchema#string

Harald H Hjelde

http://www.w3.org/2001/XMLSchema#string

Sveinung Sørhaug

http://www.w3.org/2001/XMLSchema#string

Tora S Solheim

http://www.w3.org/2001/XMLSchema#string

Tore Amundsen

http://www.w3.org/2001/XMLSchema#string

P2860

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Incomplete quality of life data in randomized trials: missing forms.

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

Assessing quality of life on the day of chemotherapy administration underestimates patients' true symptom burden.

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients.

P304

737-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1279748

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stein Kaasa

P577

2017-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28117614

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

Measurement of health-related quality of life during chemotherapy - the importance of timing.

about

P2860

P2860

Measurement of health-related quality of life during chemotherapy - the importance of timing.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921